772 related articles for article (PubMed ID: 26577995)
1. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
2. Folate acid-Cyclodextrin/Docetaxel induces apoptosis in KB cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo.
Tao J; Xu J; Chen F; Xu B; Gao J; Hu Y
Eur J Pharm Sci; 2018 Jan; 111():540-548. PubMed ID: 29097305
[TBL] [Abstract][Full Text] [Related]
3. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
[TBL] [Abstract][Full Text] [Related]
5. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
[TBL] [Abstract][Full Text] [Related]
7. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
8. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
10. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
11. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.
Shi J; Zhang H; Wang L; Li L; Wang H; Wang Z; Li Z; Chen C; Hou L; Zhang C; Zhang Z
Biomaterials; 2013 Jan; 34(1):251-61. PubMed ID: 23069706
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
[TBL] [Abstract][Full Text] [Related]
14. Folic Acid Functionalized γ-Cyclodextrin C₆₀, A Novel Vehicle for Tumor-Targeted Drug Delivery.
Liu Y; Pu Y; Sun L; Yao H; Zhao B; Zhang R; Zhang Y
J Biomed Nanotechnol; 2016 Jul; 12(7):1393-403. PubMed ID: 29336534
[TBL] [Abstract][Full Text] [Related]
15. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
[TBL] [Abstract][Full Text] [Related]
16. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
Mizusako H; Tagami T; Hattori K; Ozeki T
J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
[TBL] [Abstract][Full Text] [Related]
17. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
[TBL] [Abstract][Full Text] [Related]
18. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
19. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
Wang L; Li M; Zhang N
Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
[TBL] [Abstract][Full Text] [Related]
20. An Integrative Folate-Based Metal Complex Nanotube as a Potent Antitumor Nanomedicine as Well as an Efficient Tumor-Targeted Drug Carrier.
Liu LX; Li BX; Wang QY; Dong ZP; Li HM; Jin QM; Hong H; Zhang J; Wang Y
Bioconjug Chem; 2016 Dec; 27(12):2863-2873. PubMed ID: 27802029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]